Search Results - "Ladhani, Shamez"

COVID-19 vaccination for children aged 5-11 years by Ladhani, Shamez N

Get full text

Causation or confounding: why controls are critical for characterizing long COVID by Amin-Chowdhury, Zahin, Ladhani, Shamez N.

Get full text

Children and COVID-19 in schools by Ladhani, Shamez N

“…The benefits of in-person schooling with mitigations in place outweigh the risks of COVID-19 for children…”
Get full text

SARS-CoV-2 infection and transmission in educational settings: a prospective, cross-sectional analysis of infection clusters and outbreaks in England by Ismail, Sharif A, Saliba, Vanessa, Lopez Bernal, Jamie, Ramsay, Mary E, Ladhani, Shamez N

“…Understanding severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and transmission in educational settings is crucial for ensuring the…”
Get full text

Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in England by Ladhani, Shamez N, Andrews, Nick, Parikh, Sydel R, Campbell, Helen, White, Joanne, Edelstein, Michael, Bai, Xilian, Lucidarme, Jay, Borrow, Ray, Ramsay, Mary E

“…A meningococcal group B vaccine was introduced in the United Kingdom as part of the infant vaccination program. Investigators from Public Health England…”
Get full text

Crossing the Rubicon: A fine line between waiting and vaccinating adolescents against COVID-19 by Ladhani, Shamez N

“…Several countries with advanced adult COVID-19 immunisation programmes have already started vaccinating adolescents with an mRNA vaccine that recently received…”
Get full text

Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study by Waight, Pauline A, BSc, Andrews, Nicholas J, PhD, Ladhani, Shamez N, MD, Sheppard, Carmen L, PhD, Slack, Mary P E, FRCPath, Miller, Elizabeth, Prof

“…Summary Background The 13-valent pneumococcal conjugate vaccine (PCV13) protects against key serotypes that increased after routine immunisation with the…”
Get full text

Face masking for children - time to reconsider by Ladhani, Shamez N

Get full text

COVID-19 vaccination during pregnancy: coverage and safety by Blakeway, Helena, Prasad, Smriti, Kalafat, Erkan, Heath, Paul T., Ladhani, Shamez N., Le Doare, Kirsty, Magee, Laura A., O’Brien, Pat, Rezvani, Arezou, von Dadelszen, Peter, Khalil, Asma

“…Concerns have been raised regarding a potential surge of COVID-19 in pregnancy, secondary to the rising numbers of COVID-19 in the community, easing of…”
Get full text

Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines by Andrews, Nick, Tessier, Elise, Stowe, Julia, Gower, Charlotte, Kirsebom, Freja, Simmons, Ruth, Gallagher, Eileen, Thelwall, Simon, Groves, Natalie, Dabrera, Gavin, Myers, Richard, Campbell, Colin N.J, Amirthalingam, Gayatri, Edmunds, Matt, Zambon, Maria, Brown, Kevin, Hopkins, Susan, Chand, Meera, Ladhani, Shamez N, Ramsay, Mary, Lopez Bernal, Jamie

“…A test-negative case–control study involving more than 6 million persons in England who received two doses of the ChAdOx1-S or BNT162b2 vaccine (interval, 3 to…”
Get full text

Deaths in children and young people in England after SARS-CoV-2 infection during the first pandemic year by Smith, Clare, Odd, David, Harwood, Rachel, Ward, Joseph, Linney, Mike, Clark, Matthew, Hargreaves, Dougal, Ladhani, Shamez N., Draper, Elizabeth, Davis, Peter J., Kenny, Simon E., Whittaker, Elizabeth, Luyt, Karen, Viner, Russell, Fraser, Lorna K.

“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is rarely fatal in children and young people (CYP, <18 years old), but quantifying the…”
Get full text

Systematic review and meta-analysis of the effectiveness and perinatal outcomes of COVID-19 vaccination in pregnancy by Prasad, Smriti, Kalafat, Erkan, Blakeway, Helena, Townsend, Rosemary, O’Brien, Pat, Morris, Edward, Draycott, Tim, Thangaratinam, Shakila, Le Doare, Kirsty, Ladhani, Shamez, von Dadelszen, Peter, Magee, Laura A., Heath, Paul, Khalil, Asma

“…Safety and effectiveness of COVID-19 vaccines during pregnancy is a particular concern affecting vaccination uptake by this vulnerable group. Here we evaluated…”
Get full text

Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England by Amirthalingam, Gayatri, Bernal, Jamie Lopez, Andrews, Nick J., Whitaker, Heather, Gower, Charlotte, Stowe, Julia, Tessier, Elise, Subbarao, Sathyavani, Ireland, Georgina, Baawuah, Frances, Linley, Ezra, Warrener, Lenesha, O’Brien, Michelle, Whillock, Corinne, Moss, Paul, Ladhani, Shamez N., Brown, Kevin E., Ramsay, Mary E.

“…The UK prioritised delivery of the first dose of BNT162b2 (Pfizer/BioNTech) and AZD1222 (AstraZeneca) vaccines by extending the interval between doses up to 12…”
Get full text

Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study by Andrews, Nick J, PhD, Waight, Pauline A, BSc, Burbidge, Polly, BSc, Pearce, Emma, BSc, Roalfe, Lucy, BSc, Zancolli, Marta, PhD, Slack, Mary, FRCPath, Ladhani, Shamez N, MD, Miller, Elizabeth, FRCPath, Goldblatt, David, Prof

“…Summary Background Efficacy of the 13-valent pneumococcal conjugate vaccine (PCV13) was inferred before licensure from an aggregate correlate of protection…”
Get full text

Delayed access to care and late presentations in children during the COVID-19 pandemic: a snapshot survey of 4075 paediatricians in the UK and Ireland by Lynn, Richard M, Avis, Jacob L, Lenton, Simon, Amin-Chowdhury, Zahin, Ladhani, Shamez N

“…Table 1 Summary of the main conditions reported in children and the perinatal period and deaths where delayed presentation was considered by the reporting…”
Get full text

Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in Australia by Marshall, Helen S, McMillan, Mark, Koehler, Ann P, Lawrence, Andrew, Sullivan, Thomas R, MacLennan, Jenny M, Maiden, Martin C.J, Ladhani, Shamez N, Ramsay, Mary E, Trotter, Caroline, Borrow, Ray, Finn, Adam, Kahler, Charlene M, Whelan, Jane, Vadivelu, Kumaran, Richmond, Peter

“…Recently, a meningococcal vaccine for group B was approved and deployed into clinical practice. In this trial, the effect of widespread use of this vaccine on…”
Get full text

Stillbirths During the COVID-19 Pandemic in England, April-June 2020 by Stowe, Julia, Smith, Helen, Thurland, Kate, Ramsay, Mary E, Andrews, Nick, Ladhani, Shamez N

“…This study uses National Health Service data to compare the stillbirth rate overall and regionally during the initial April-June 2020 coronavirus lockdown vs…”
Get full text

Effects of the COVID-19 pandemic on maternal and perinatal outcomes: a systematic review and meta-analysis by Chmielewska, Barbara, Barratt, Imogen, Townsend, Rosemary, Kalafat, Erkan, van der Meulen, Jan, Gurol-Urganci, Ipek, O'Brien, Pat, Morris, Edward, Draycott, Tim, Thangaratinam, Shakila, Le Doare, Kirsty, Ladhani, Shamez, von Dadelszen, Peter, Magee, Laura, Khalil, Asma

“…The COVID-19 pandemic has had a profound impact on health-care systems and potentially on pregnancy outcomes, but no systematic synthesis of evidence of this…”
Get full text

Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort study by Ladhani, Shamez N, Collins, Sarah, Djennad, Abdelmajid, Sheppard, Carmen L, Borrow, Ray, Fry, Norman K, Andrews, Nicholas J, Miller, Elizabeth, Ramsay, Mary E

“…Pneumococcal conjugate vaccines (PCVs) have substantially reduced the incidence of invasive pneumococcal disease caused by vaccine serotypes; however,…”
Get full text

Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study by Parikh, Sydel R, MSc, Andrews, Nick J, Prof, Beebeejaun, Kazim, MSc, Campbell, Helen, MSc, Ribeiro, Sonia, BA, Ward, Charlotte, MSc, White, Joanne M, FFPH, Borrow, Ray, Prof, Ramsay, Mary E, FFPHM, Ladhani, Shamez N, Dr

“…Summary Background In September, 2015, the UK became the first country to introduce the multicomponent group B meningococcal (MenB) vaccine (4CMenB, Bexsero)…”
Get full text